Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Leukemia ; 20(1): 42-7, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16327841

ABSTRACT

Combination chemotherapy may induce remission from acute myeloid leukemia (AML), but validated criteria for treatment of elderly are lacking. The remission intention (RI) rate for elderly patients, as reported to the Swedish Leukemia Registry, was known to be different when comparing the six health care regions, but the consequences of different management are unknown. The Leukemia Registry, containing 1672 AML patients diagnosed between 1997 and 2001, with 98% coverage and a median follow-up of 4 years, was completed with data from the compulsory cancer and population registries. Among 506 treated and untreated patients aged 70-79 years with AML (non-APL), there was a direct correlation between the RI rate in each health region (range 36-76%) and the two-year overall survival, with no censored observations (6-21%) (chi-squared for trend=11.3, P<0.001; r2=0.86, P<0.02, nonparametric). A 1-month landmark analysis showed significantly better survival in regions with higher RI rates (P=0.003). Differences could not be explained by demographics, and was found in both de novo and secondary leukemias. The 5-year survival of the overall population aged 70-79 years was similar between the regions. Survival of 70-79-year-old AML patients is better in regions where more elderly patients are judged eligible for remission induction.


Subject(s)
Attitude of Health Personnel , Leukemia, Myeloid/drug therapy , Patient Selection , Acute Disease , Adolescent , Adult , Age Distribution , Age Factors , Aged , Aged, 80 and over , Follow-Up Studies , Humans , Leukemia, Myeloid/mortality , Middle Aged , Registries , Remission Induction , Survival Rate , Sweden/epidemiology , Treatment Outcome
2.
Scand Audiol ; 29(3): 171-4, 2000.
Article in English | MEDLINE | ID: mdl-10990015

ABSTRACT

Wind noise was measured in four behind-the-ear hearing instruments with different microphone openings. A silent airflow of 7 m/s was directed toward the ear of a Kemar head and the resulting wind noise was measured. The amplification was set to an insertion gain of 35 dB at 1.6 kHz. The wind noise amplitude at the position of the drum ranged from 84 to 97 dB(A). The hearing instrument with a partially covered microphone entrance proved best, whereas one with an open microphone entrance had the poorest performance. A reduction in wind noise of 6-17 dB could be achieved in all hearing instruments by using a simple windscreen made of Styrofoam. The windscreen affected the frequency response by less than 2 dB. By subtracting the insertion gain from the wind noise, an equivalent wind noise could be presented as a function of frequency. A considerable difference was found between the wind noise sensitivity in different hearing instruments. All could be improved by a windscreen without adversely affecting the frequency response.


Subject(s)
Hearing Aids , Noise , Acoustic Stimulation/instrumentation , Auditory Perception/physiology , Correction of Hearing Impairment , Equipment Design , Humans , Noise/adverse effects , Patient Satisfaction , Pilot Projects , Wind
SELECTION OF CITATIONS
SEARCH DETAIL